Valens is a pot grower with a sizable stake in Canada’s cannabis 2.0 industry.
Valens partners with Thermo Fisher Scientific to provide third-party testing on harvested cannabis to meet standards set by Health Canada.
2 most popular CBD brand in the U.S., with over 7,000 wholesale locations and a 94% customer satisfaction rating.
The stock trades at just 6.7 times revenue, a bit below the average valuation of 7.8 times revenue in the sector.
In addition to selling cannabis, the Planet 13 store hosts a coffee shop, restaurant, and interactive exhibits like an in-house production facility.
Due to strong tourist activity, Planet 13 Holdings brought in $10.7 million in revenue in April, which is equivalent to its entire second-quarter 2020 sales.
With business doing so great, the firm plans to open up eight more mega-dispensaries by the end of 2026.
For marijuana investors willing to take on the inherent risks of the industry, I think Planet 13 Holdings is a great stock to add to your watchlist.